{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:13Z","timestamp":1791229633181,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98043-7","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T16:41:06Z","timestamp":1744562466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of frailty on the long-term prognosis of the elderly with hepatocellular carcinoma treated with transarterial chemoembolization"],"prefix":"10.1038","volume":"15","author":[{"given":"Yu-Fei","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,13]]},"reference":[{"key":"98043_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"98043_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.7326\/M14-0500","volume":"160","author":"LB Vater","year":"2014","unstructured":"Vater, L. B. et al. What are cancer centers advertising to the public? A content analysis. Ann. Intern. Med. 160, 813\u2013820 (2014).","journal-title":"Ann. Intern. Med."},{"key":"98043_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig, M. et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J. Hepatol. 76, 681\u2013693 (2022).","journal-title":"J. Hepatol."},{"key":"98043_CR4","first-page":"1389","volume":"11","author":"YK Li","year":"2024","unstructured":"Li, Y. K. et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: A retrospective study. J. Hepatol. 11, 1389\u20131402 (2024).","journal-title":"J. Hepatol."},{"key":"98043_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2021.04.009","volume":"137","author":"APL Tolley","year":"2021","unstructured":"Tolley, A. P. L. et al. Objectively measured physical activity is associated with frailty in community-dwelling older adults: A systematic review. J. Clin. Epidemiol. 137, 218\u2013230 (2021).","journal-title":"J. Clin. Epidemiol."},{"key":"98043_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg, A. et al. Frailty in elderly people. Lancet 381, 752\u2013762 (2013).","journal-title":"Lancet"},{"key":"98043_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/ALN.0000000000003257","volume":"133","author":"SD Aucoin","year":"2020","unstructured":"Aucoin, S. D. et al. Accuracy and feasibility of clinically applied frailty instruments before surgery: A systematic review and Meta-analysis. Anesthesiology 133, 78\u201395 (2020).","journal-title":"Anesthesiology"},{"key":"98043_CR8","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00464-016-5253-7","volume":"31","author":"M Chimukangara","year":"2017","unstructured":"Chimukangara, M. et al. A 5-item frailty index based on NSQIP data correlates with outcomes following paraesophageal hernia repair. Surg. Endosc. 31, 2509\u20132519 (2017).","journal-title":"Surg. Endosc"},{"key":"98043_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3171\/2023.7.JNS231214","volume":"140","author":"T Lucido","year":"2024","unstructured":"Lucido, T. et al. The 5-factor modified frailty index as a prognostic factor of stereotactic radiosurgery for metastatic disease to the brain. J. Neurosurg. 140, 929\u2013937 (2024).","journal-title":"J. Neurosurg."},{"key":"98043_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12957-023-03186-4","volume":"21","author":"L Huang","year":"2023","unstructured":"Huang, L. et al. Application of MFI-5 in severe complications and unfavorable outcomes after radical resection of colorectal cancer. World J. Surg. Oncol. 21, 307 (2023).","journal-title":"World J. Surg. Oncol."},{"key":"98043_CR11","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3390\/cancers14112575","volume":"14","author":"X Hu","year":"2022","unstructured":"Hu, X. et al. Added value of viscoelasticity for MRI-Based prediction of Ki-67 expression of hepatocellular carcinoma using a deep learning combined radiomics (DLCR) model. Cancers (Basel). 14, 2575 (2022).","journal-title":"Cancers (Basel)"},{"key":"98043_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","volume":"1","author":"YR Huo","year":"2015","unstructured":"Huo, Y. R. et al. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: A systematic review and Meta-analysis. JAMA Oncol. 1, 756\u2013765 (2015).","journal-title":"JAMA Oncol."},{"key":"98043_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix, J. et al. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. GASTROENTEROL 150, 835\u2013853 (2016).","journal-title":"GASTROENTEROL"},{"key":"98043_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jncc.2023.02.001","volume":"3","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis. J. Natl. Cancer Cent. 3, 175\u2013185 (2023).","journal-title":"J. Natl. Cancer Cent."},{"key":"98043_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S462168","volume":"11","author":"YK Li","year":"2024","unstructured":"Li, Y. K. et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: A retrospective study. J. Hepatocell Carcinoma. 11, 1389\u20131402 (2024).","journal-title":"J. Hepatocell Carcinoma"},{"key":"98043_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/oncologie-2023-0360","volume":"26","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma. ONCOLOGIE 26, 91\u2013103 (2024).","journal-title":"ONCOLOGIE"},{"key":"98043_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.32604\/biocell.2024.048244","volume":"48","author":"Y MA","year":"2024","unstructured":"MA, Y. et al. Bioinformatics analysis and experimental validation of cystathionine-gamma-lyase as a potential prognosis biomarker in hepatocellular carcinoma. Biocell 48, 463\u2013471 (2024).","journal-title":"Biocell"},{"key":"98043_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41598-024-84368-2","volume":"15","author":"H Chu","year":"2025","unstructured":"Chu, H. et al. PNMA1 is a novel immune modulator and therapeutic target in hepatocellular carcinoma linked to bile acid metabolism. Sci. Rep. 15, 738 (2025).","journal-title":"Sci. Rep."},{"key":"98043_CR19","doi-asserted-by":"publisher","first-page":"646410","DOI":"10.3389\/fonc.2021.646410","volume":"11","author":"Q Tang","year":"2021","unstructured":"Tang, Q. et al. Efficacy and safety of transarterial chemoembolization in elderly patients of advanced hepatocellular carcinoma with portal vein tumor thrombus: A retrospective study. Front. Oncol. 11, 646410 (2021).","journal-title":"Front. Oncol."},{"key":"98043_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12957-023-03150-2","volume":"21","author":"T Ogata","year":"2023","unstructured":"Ogata, T. et al. World J Surg oncol. World J. Surg. Oncol. 21, 268 (2023).","journal-title":"World J. Surg. Oncol."},{"key":"98043_CR21","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.3390\/cancers14184422","volume":"14","author":"S Brozzetti","year":"2022","unstructured":"Brozzetti, S. et al. Surgical resection is superior to TACE in the treatment of HCC in a well selected cohort of BCLC-B elderly Patients-A retrospective observational study. Cancers (Basel). 14, 4422 (2022).","journal-title":"Cancers (Basel)"},{"key":"98043_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3350\/cmh.2016.0054","volume":"22","author":"SH Yoo","year":"2016","unstructured":"Yoo, S. H. et al. Preemptive antiviral therapy with Entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization. Clin. Mol. Hepatol. 22, 458\u2013465 (2016).","journal-title":"Clin. Mol. Hepatol."},{"key":"98043_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/cancers11040509","volume":"11","author":"YE Chon","year":"2019","unstructured":"Chon, Y. E. et al. Development of a new nomogram including Neutrophil-to-Lymphocyte ratio to predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancers (Basel). 11, 509 (2019).","journal-title":"Cancers (Basel)"},{"key":"98043_CR24","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2024","unstructured":"Li, J. et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front. Immunol. 15, 1519999 (2024).","journal-title":"Front. Immunol."},{"key":"98043_CR25","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/biomedicines10102361","volume":"10","author":"BWR Tay","year":"2022","unstructured":"Tay, B. W. R. et al. Comparable outcomes in early hepatocellular carcinomas treated with Trans-Arterial chemoembolization and radiofrequency ablation. Biomedicines 10, 2361 (2022).","journal-title":"Biomedicines"},{"key":"98043_CR26","doi-asserted-by":"publisher","first-page":"914385","DOI":"10.3389\/fonc.2022.914385","volume":"12","author":"XG Yang","year":"2022","unstructured":"Yang, X. G. et al. Efficacy and safety of transarterial chemoembolization combining Sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis. Front. Oncol. 12, 914385 (2022).","journal-title":"Front. Oncol."},{"key":"98043_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jamasurg.2016.3479","volume":"152","author":"F Gani","year":"2017","unstructured":"Gani, F. et al. Use of the modified frailty index in the American college of surgeons National surgical improvement program database: highlighting the problem of missing data. JAMA Surg. 152, 205\u2013207 (2017).","journal-title":"JAMA Surg."},{"key":"98043_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00423-024-03483-w","volume":"409","author":"A Khalid","year":"2024","unstructured":"Khalid, A. et al. Modified 5-Item frailty index (mFI-5) May predict postoperative outcomes after pancreatoduodenectomy for pancreatic cancer. Langenbecks Arch. Surg. 409, 286 (2024).","journal-title":"Langenbecks Arch. Surg."},{"key":"98043_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/lt.25953","volume":"27","author":"N Mahmud","year":"2021","unstructured":"Mahmud, N. et al. Frailty is a risk factor for postoperative mortality in patients with cirrhosis undergoing diverse major surgeries. Liver Transpl. 27, 699\u2013710 (2021).","journal-title":"Liver Transpl."},{"key":"98043_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/gerona\/glac214","volume":"78","author":"E Kravvariti","year":"2023","unstructured":"Kravvariti, E. et al. Geriatric frailty is associated with oxidative stress, accumulation, and defective repair of DNA Double-Strand breaks independently of age and comorbidities. J. Gerontol. A. 78, 603\u2013610 (2023).","journal-title":"J. Gerontol. A"},{"key":"98043_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaci.2010.08.011","volume":"126","author":"PJ Busse","year":"2010","unstructured":"Busse, P. J. et al. Age-related changes in immune function: effect on airway inflammation. J. Allergy Clin. Immunol. 126, 690\u2013699 (2010). quiz 700\u2009\u2013\u2009691.","journal-title":"J. Allergy Clin. Immunol."},{"key":"98043_CR32","first-page":"466","volume":"2","author":"H Li","year":"2011","unstructured":"Li, H. et al. Frailty, inflammation, and immunity. Aging Dis. 2, 466\u2013473 (2011).","journal-title":"Aging Dis."},{"key":"98043_CR33","first-page":"2674","volume":"103","author":"[Chinese clinical practice guidelines for","year":"2023","unstructured":"[Chinese clinical practice guidelines for. Transarterial chemoembolization of hepatocellular carcinoma (2023 edition)]. Zhonghua Yi Xue Za Zhi. 103, 2674\u20132694 (2023).","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98043-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98043-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98043-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T16:41:07Z","timestamp":1744562467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98043-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98043"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98043-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,13]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the ethical standards described in the 1964 Declaration of Helsinki and its later amendments. Ethical approval was obtained from the Affiliated Hospital of Xuzhou Medical University, Approval Number XYFY2022-KL481-01. Written informed consent was obtained from all participants prior to their involvement in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of any potentially identifiable data was obtained from all participants. The consent form clearly stated the purpose of the publication and the potential for data sharing, ensuring that participants were fully aware of and agreed to the use of their information in this manner.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"No artificial intelligence (AI) tools were used in the preparation of this manuscript. The research design, data collection, analysis, interpretation of results, and writing of the manuscript were all conducted without the assistance of AI tools.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence tools"}}],"article-number":"12746"}}